To evaluate the practice of pharmaceutical care in oncology clinical pharmacists after the implementation of the charging policy for pharmaceutical service.
The clinical data of patients who received paid pharmaceutical care in the oncology department of a tertiary hospital in Beijing from November 2024 to July 2025 were retrospectively analyzed, including monitoring content, monitoring drugs, monitoring type and intervention.
A total of 131 patients were enrolled, and the average number of monitored patients was 14.55 per month. A total of 361 pharmaceutical care suggestions were put forward, of which 154 (42.66%) were intervention suggestions, of which 207 (57.34%) were pharmaceutical evaluation recommendations. The main suggestions for intervention were: 42 suggestions for the treatment of adverse drug reactions (27.27%), 42 suggestions for the formulation/adjustment of medication regimens (27.27%), etc. The main recommendations included risk monitoring of adverse drug reactions (103 recommendations, 49.76%), medication education (67 recommendations, 32.37%), etc.
This study describes the initial practice after the implementation of the policy, which can provide a baseline for subsequent controlled studies and also provide a new idea for the implementation of the model of inpatient pharmaceutical care.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |